|
WO2020109316A1
|
|
Methods for diagnosing and/or treating acute or chronic liver, kidney or lung disease
|
|
EP3779455A1
|
|
Lipid signatures for determining the outcome of embryo implantation during in vitro fertilization
|
|
EP3674421A1
|
|
Methods for the prognosis of prostate cancer
|
|
EP3669642A1
|
|
Capsule for experiments
|
|
EP3417860A1
|
|
Use of ciclopirox as a modulator of the heme group biosynthesis and in the treatment of porphyrias and other diseases
|
|
EP3315129A1
|
|
Use of ciclopirox for the treatment of congenital erythropoietic porphyria
|
|
KR20180039162A
|
|
Methods and compositions for treating liver diseases and conditions
|
|
AU2016293834A1
|
|
MCJ inhibitors for use in treating drug-induced diseases and conditions
|
|
CA2807174A1
|
|
Use of inhibitors of porphobilinogen deaminase in the treatment of congenital erythropoietic porphyria
|
